FDx Advisors’s Core Laboratories CLB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-6,411
| Closed | -$335K | – | 656 |
|
|
2019
Q2 | $335K | Sell |
6,411
-2,111
| -25% | -$110K | 0.01% | 598 |
|
|
2019
Q1 | $587K | Buy |
8,522
+4,431
| +108% | +$305K | 0.02% | 429 |
|
|
2018
Q4 | $244K | Sell |
4,091
-8,232
| -67% | -$491K | 0.02% | 471 |
|
|
2018
Q3 | $1.43M | Buy |
12,323
+1,257
| +11% | +$146K | 0.05% | 271 |
|
|
2018
Q2 | $1.4M | Sell |
11,066
-1,779
| -14% | -$225K | 0.05% | 297 |
|
|
2018
Q1 | $1.39M | Sell |
12,845
-3,418
| -21% | -$370K | 0.04% | 403 |
|
|
2017
Q4 | $1.78M | Sell |
16,263
-139
| -0.8% | -$15.2K | 0.05% | 349 |
|
|
2017
Q3 | $1.62M | Buy |
16,402
+2,167
| +15% | +$214K | 0.04% | 381 |
|
|
2017
Q2 | $1.44M | Buy |
14,235
+1,404
| +11% | +$142K | 0.04% | 412 |
|
|
2017
Q1 | $1.48M | Buy |
12,831
+559
| +5% | +$64.6K | 0.05% | 393 |
|
|
2016
Q4 | $1.47M | Buy |
12,272
+3,966
| +48% | +$476K | 0.04% | 381 |
|
|
2016
Q3 | $933K | Buy |
8,306
+1,119
| +16% | +$126K | 0.04% | 409 |
|
|
2016
Q2 | $890K | Sell |
7,187
-532
| -7% | -$65.9K | 0.04% | 400 |
|
|
2016
Q1 | $868K | Buy |
7,719
+828
| +12% | +$93.1K | 0.04% | 407 |
|
|
2015
Q4 | $749K | Buy |
6,891
+4,711
| +216% | +$512K | 0.03% | 439 |
|
|
2015
Q3 | $218K | Sell |
2,180
-3,478
| -61% | -$347K | 0.02% | 696 |
|
|
2015
Q2 | $666K | Buy |
5,658
+2,858
| +102% | +$336K | 0.03% | 475 |
|
|
2015
Q1 | $291K | Sell |
2,800
-13,842
| -83% | -$1.44M | 0.01% | 1238 |
|
|
2014
Q4 | $2M | Sell |
16,642
-466
| -3% | -$56.1K | 0.12% | 152 |
|
|
2014
Q3 | $2.5M | Buy |
17,108
+2,628
| +18% | +$385K | 0.16% | 128 |
|
|
2014
Q2 | $2.42M | Buy |
14,480
+5,015
| +53% | +$838K | 0.16% | 138 |
|
|
2014
Q1 | $1.88M | Buy |
9,465
+4,372
| +86% | +$867K | 0.16% | 148 |
|
|
2013
Q4 | $972K | Buy |
5,093
+3,482
| +216% | +$665K | 0.1% | 205 |
|
|
2013
Q3 | $273K | Sell |
1,611
-815
| -34% | -$138K | 0.03% | 479 |
|
|
2013
Q2 | $368K | Buy |
+2,426
| New | +$368K | 0.05% | 326 |
|